Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia

Sangkyou Lee, Joon Jeong, Tadeusz Majewski, Steven E. Scherer, Mi Sook Kim, Tomasz Tuziak, Kuang S. Tang, Keith Baggerly, Herbert Barton Grossman, Jain Hua Zhou, Lanlan Shen, Jolanta Bondaruk, Saira S. Ahmed, Susmita Samanta, Philippe Spiess, Xifeng Wu, Slawomir Filipek, David McConkey, Menashe Bar-Eli, Jean Pierre IssaWilliam F. Benedict, Bogdan Czerniak

Research output: Contribution to journalArticle

Abstract

We used human bladder cancer as a model system and the whole-organ histologic and genetic mapping strategy to identify clonal genetic hits associated with growth advantage, tracking the evolution of bladder cancer from intraurothelial precursor lesions. Six putative chromosomal regions critical for clonal expansion of intraurothelial neoplasia and development of bladder cancer were identified by using this approach. Focusing on one of the regions, which includes the model tumor suppressor RB1, we performed allelotyping of single-nucleotide polymorphic sites and identified a 1.34-Mb segment around RB1 characterized by a loss of polymorphism associated with the initial expansion of in situ neoplasia. This segment contains several positional candidate genes referred to by us as forerunner genes that may contribute to such expansion. We subsequently concentrated our efforts on the two neighbor genes flanking RB1, namely ITM2B and CHC1L, as well as P2RY5, which is located inside RB1. Here, we report that ITM2B and P2RY5 modulated cell survival and were silenced by methylation or point mutations, respectively, and thus by functional loss may contribute to the growth advantage of neoplasia. We also show that homozygous inactivation of P2RY5 was antecedent to the loss of RB1 during tumor development, and that nucleotide substitutions in P2RY5 represent a cancer predisposing factor.

Original languageEnglish (US)
Pages (from-to)13732-13737
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number34
DOIs
StatePublished - Aug 21 2007
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Genes
Neoplasms
Nucleotides
Growth
Point Mutation
Causality
Methylation
Cell Survival

Keywords

  • Bladder cancer
  • Single-nucleotide polymorphic sites
  • Whole-organ histologic and genetic mapping

ASJC Scopus subject areas

  • General

Cite this

Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. / Lee, Sangkyou; Jeong, Joon; Majewski, Tadeusz; Scherer, Steven E.; Kim, Mi Sook; Tuziak, Tomasz; Tang, Kuang S.; Baggerly, Keith; Grossman, Herbert Barton; Zhou, Jain Hua; Shen, Lanlan; Bondaruk, Jolanta; Ahmed, Saira S.; Samanta, Susmita; Spiess, Philippe; Wu, Xifeng; Filipek, Slawomir; McConkey, David; Bar-Eli, Menashe; Issa, Jean Pierre; Benedict, William F.; Czerniak, Bogdan.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 34, 21.08.2007, p. 13732-13737.

Research output: Contribution to journalArticle

Lee, S, Jeong, J, Majewski, T, Scherer, SE, Kim, MS, Tuziak, T, Tang, KS, Baggerly, K, Grossman, HB, Zhou, JH, Shen, L, Bondaruk, J, Ahmed, SS, Samanta, S, Spiess, P, Wu, X, Filipek, S, McConkey, D, Bar-Eli, M, Issa, JP, Benedict, WF & Czerniak, B 2007, 'Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia', Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13732-13737. https://doi.org/10.1073/pnas.0701771104
Lee, Sangkyou ; Jeong, Joon ; Majewski, Tadeusz ; Scherer, Steven E. ; Kim, Mi Sook ; Tuziak, Tomasz ; Tang, Kuang S. ; Baggerly, Keith ; Grossman, Herbert Barton ; Zhou, Jain Hua ; Shen, Lanlan ; Bondaruk, Jolanta ; Ahmed, Saira S. ; Samanta, Susmita ; Spiess, Philippe ; Wu, Xifeng ; Filipek, Slawomir ; McConkey, David ; Bar-Eli, Menashe ; Issa, Jean Pierre ; Benedict, William F. ; Czerniak, Bogdan. / Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 34. pp. 13732-13737.
@article{7ca8a08a18c5457ca90260672036b70a,
title = "Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia",
abstract = "We used human bladder cancer as a model system and the whole-organ histologic and genetic mapping strategy to identify clonal genetic hits associated with growth advantage, tracking the evolution of bladder cancer from intraurothelial precursor lesions. Six putative chromosomal regions critical for clonal expansion of intraurothelial neoplasia and development of bladder cancer were identified by using this approach. Focusing on one of the regions, which includes the model tumor suppressor RB1, we performed allelotyping of single-nucleotide polymorphic sites and identified a 1.34-Mb segment around RB1 characterized by a loss of polymorphism associated with the initial expansion of in situ neoplasia. This segment contains several positional candidate genes referred to by us as forerunner genes that may contribute to such expansion. We subsequently concentrated our efforts on the two neighbor genes flanking RB1, namely ITM2B and CHC1L, as well as P2RY5, which is located inside RB1. Here, we report that ITM2B and P2RY5 modulated cell survival and were silenced by methylation or point mutations, respectively, and thus by functional loss may contribute to the growth advantage of neoplasia. We also show that homozygous inactivation of P2RY5 was antecedent to the loss of RB1 during tumor development, and that nucleotide substitutions in P2RY5 represent a cancer predisposing factor.",
keywords = "Bladder cancer, Single-nucleotide polymorphic sites, Whole-organ histologic and genetic mapping",
author = "Sangkyou Lee and Joon Jeong and Tadeusz Majewski and Scherer, {Steven E.} and Kim, {Mi Sook} and Tomasz Tuziak and Tang, {Kuang S.} and Keith Baggerly and Grossman, {Herbert Barton} and Zhou, {Jain Hua} and Lanlan Shen and Jolanta Bondaruk and Ahmed, {Saira S.} and Susmita Samanta and Philippe Spiess and Xifeng Wu and Slawomir Filipek and David McConkey and Menashe Bar-Eli and Issa, {Jean Pierre} and Benedict, {William F.} and Bogdan Czerniak",
year = "2007",
month = "8",
day = "21",
doi = "10.1073/pnas.0701771104",
language = "English (US)",
volume = "104",
pages = "13732--13737",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "34",

}

TY - JOUR

T1 - Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia

AU - Lee, Sangkyou

AU - Jeong, Joon

AU - Majewski, Tadeusz

AU - Scherer, Steven E.

AU - Kim, Mi Sook

AU - Tuziak, Tomasz

AU - Tang, Kuang S.

AU - Baggerly, Keith

AU - Grossman, Herbert Barton

AU - Zhou, Jain Hua

AU - Shen, Lanlan

AU - Bondaruk, Jolanta

AU - Ahmed, Saira S.

AU - Samanta, Susmita

AU - Spiess, Philippe

AU - Wu, Xifeng

AU - Filipek, Slawomir

AU - McConkey, David

AU - Bar-Eli, Menashe

AU - Issa, Jean Pierre

AU - Benedict, William F.

AU - Czerniak, Bogdan

PY - 2007/8/21

Y1 - 2007/8/21

N2 - We used human bladder cancer as a model system and the whole-organ histologic and genetic mapping strategy to identify clonal genetic hits associated with growth advantage, tracking the evolution of bladder cancer from intraurothelial precursor lesions. Six putative chromosomal regions critical for clonal expansion of intraurothelial neoplasia and development of bladder cancer were identified by using this approach. Focusing on one of the regions, which includes the model tumor suppressor RB1, we performed allelotyping of single-nucleotide polymorphic sites and identified a 1.34-Mb segment around RB1 characterized by a loss of polymorphism associated with the initial expansion of in situ neoplasia. This segment contains several positional candidate genes referred to by us as forerunner genes that may contribute to such expansion. We subsequently concentrated our efforts on the two neighbor genes flanking RB1, namely ITM2B and CHC1L, as well as P2RY5, which is located inside RB1. Here, we report that ITM2B and P2RY5 modulated cell survival and were silenced by methylation or point mutations, respectively, and thus by functional loss may contribute to the growth advantage of neoplasia. We also show that homozygous inactivation of P2RY5 was antecedent to the loss of RB1 during tumor development, and that nucleotide substitutions in P2RY5 represent a cancer predisposing factor.

AB - We used human bladder cancer as a model system and the whole-organ histologic and genetic mapping strategy to identify clonal genetic hits associated with growth advantage, tracking the evolution of bladder cancer from intraurothelial precursor lesions. Six putative chromosomal regions critical for clonal expansion of intraurothelial neoplasia and development of bladder cancer were identified by using this approach. Focusing on one of the regions, which includes the model tumor suppressor RB1, we performed allelotyping of single-nucleotide polymorphic sites and identified a 1.34-Mb segment around RB1 characterized by a loss of polymorphism associated with the initial expansion of in situ neoplasia. This segment contains several positional candidate genes referred to by us as forerunner genes that may contribute to such expansion. We subsequently concentrated our efforts on the two neighbor genes flanking RB1, namely ITM2B and CHC1L, as well as P2RY5, which is located inside RB1. Here, we report that ITM2B and P2RY5 modulated cell survival and were silenced by methylation or point mutations, respectively, and thus by functional loss may contribute to the growth advantage of neoplasia. We also show that homozygous inactivation of P2RY5 was antecedent to the loss of RB1 during tumor development, and that nucleotide substitutions in P2RY5 represent a cancer predisposing factor.

KW - Bladder cancer

KW - Single-nucleotide polymorphic sites

KW - Whole-organ histologic and genetic mapping

UR - http://www.scopus.com/inward/record.url?scp=35348915886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348915886&partnerID=8YFLogxK

U2 - 10.1073/pnas.0701771104

DO - 10.1073/pnas.0701771104

M3 - Article

C2 - 17702869

AN - SCOPUS:35348915886

VL - 104

SP - 13732

EP - 13737

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 34

ER -